Skip to main content

Genomatix Licenses Software to NCI

NEW YORK, Sept. 20 (GenomeWeb News) - Genomatix Software said today that it has licensed its Genomatix Suite to the National Cancer Institute, allowing for 100 intramural researchers at all of the 21 NIH institutes to have full access to the software analysis tools and database.

 

The tools in GenomatixSuite are designed for analysis of gene regulatory networks and pathways, and also include a database of mammalian promoter DNA sequences, according to Genomatix.

 

Specific terms of the NCI deal were not disclosed.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.